In the context of the case study, explain how the issue of rheumatic heart disease in Rwanda exemplifies the upstream, midstream, and downstream approach to addressing health at the population level.

In this case, upstream means the underlying poverty and lack of financial resources in Rwanda that keep a low-income country from providing basic medical care. Midstream means the missed opportunity to treat strep throat with throat cultures and antibiotics before it becomes rheumatic fever. Downstream means Team Heart's yearly surgery to repair heart valve damage in people who already have rheumatic heart disease. The case indicates that limited resources should be directed to the midstream step, treating strep throat early, rather than letting the disease progress to the point where surgery is needed.

Rheumatic heart disease in Rwanda illustrates the layers of intervention from root causes to late complications. At the upstream level, the root cause is the country's lack of funding for health resources, a consequence of poverty. This financial condition determines that when children present with a sore throat, basic throat cultures and antibiotics may not be available. At the midstream level, the missing early diagnosis and treatment of strep throat allows the infection to advance to rheumatic fever. The case describes untreated strep throat leading to rheumatic fever, and rheumatic fever leading to life-threatening damage to the heart valves. At the downstream level, Team Heart, a volunteer group of 40 to 60 people including nurses and a cardiac surgeon, travels to Rwanda once a year to perform cardiac surgery for people with rheumatic heart disease. This surgery addresses end-stage damage, but it does not interrupt the chain that creates new cases. For a population approach with limited resources, the case points to focusing on the earlier stage that can stop progression: ensuring access to basic throat cultures and antibiotics for sore throat, which would reduce the burden of rheumatic fever and rheumatic heart disease.